OZ Biosciences offers solutions to deliver functional Proteins and Antibodies into living cells.
Deliver Functional Proteins and Antibodies into Living Cells
![Deliver Functional Proteins and Antibodies into Living Cells Deliver Functional Proteins and Antibodies into Living Cells](https://www.caltagmedsystems.co.uk/information/wp-content/uploads/protein-and-antibody-delivery-system-600x300.png)
OZ Biosciences offers solutions to deliver functional Proteins and Antibodies into living cells.
MBLI’s innovative technology, Fluoppi, simplifies the visualisation of protein-protein interaction.
Research findings indicate that neoantigens have the potential to activate tumour-specific T-cell-mediated anti-tumour immune responses.
Chimeric Antigen Receptor (CAR) T cell therapy is a revolutionary approach in the field of cancer immunotherapy.
Inflammatory bowel disease (IBD), which affects millions of people worldwide, is made up of various conditions that cause chronic inflammation of the gastrointestinal (GI) tract. The two main conditions are ulcerative colitis and Crohn’s disease. Crohn’s disease can affect any
ProSci offers reagents that can be used to study the actions of multiple immune checkpoint proteins such as CTLA-4, PD-1, & its ligands PD-L1 & PD-L2.
To support research & studies into infectious diseases, ProSci has reagents for the study of many viral disease agents inc. Covid, HIV, & Influenza.
AllCells’ has thousands of well-characterised, highly engaged recallable donors, with specific attributes, at collection sites across the US & Europe.
AllCells’ Pre-Characterised Donor Selection Program expedites screening, selecting & collecting from donors for downstream clinical manufacturing.
Key takeaways from AllCells’ VP of Donor Operations presentation on reframing the donor supply chain ecosystem to support the CGT manufacturing boom.